BIT's 18th Annual Congress of International Drug Discovery Science and Technology (IDDST-2023)
Welcome to IDDST

The Annual Congress of International Drug Discovery Science & Technology (IDDST), initiated from 2003, has been successfully organized in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA) and Kyoto (Japan) and has attracted more than 10000 participants from over 50 countries and regions in the previous 17 years. IDDST continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment.

Keynote Speakers
Dr. Luc Van Hijfte,
SVP Medicinal Chemistry, Symeres, the Netherlands
Dr. Matthias von Herrath,
Professor, La Jolla Institute; Vice President, NovoNordisk, USA
Dr. Dan Some,
Principal Scientist, Wyatt Technology Corporation, USA
Dr. Balazs Sarkadi,
Professor, Semmelweis University, Hungary
Dr. Uwe Schoenbeck,
Senior Vice President & Chief Scientific Officer, Worldwide R & D, Pfizer, USA
Dr. Zsolt Bosnyak,
Chief Medical Officer, Richter Gedeon Nyrt., France
Confirmed Renowned Speakers

Dr. Pirouz M,
Daftarian, Director of Scientific Engagement, Crown Biosciences and MBLI, USA
Dr. Volker Lang,
Managing Director, AbCheck, Czech Republic
Dr. Thijs (Mattheus) Paulus van Iersel,
Senior Director of Clinical Pharmacology, Scientific Affairs - Clinical Pharmacology, PRA Health Sciences, The Netherlands
Dr. Iain L. O. Buxton,
Foundation Professor, University of Nevada, USA
Dr. Alexey RAK,
Director of Bio Structure and Biophysics, Sanofi R&D, France
Dr. Loui Madakamutil,
SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA
Dr. Marcus Bauser,
Director, Medicinal Chemistry, Bayer AG, Germany
Dr. Henk Leeuwis,
Vice President, LioniX International, the Netherlands
Dr. Florian Montel,
Head of & CNS Project Leader, BoehringerIngelheim, Germany
Dr. Juhaeri JUHAERI,
Vice President and Head, Epidemiology and Benefit-Risk Evaluation, Sanofi, USA
Dr. Mehrdad Ghashghaeinia,
Professor, University Medical Center Schleswig-Holstein, Germany
Dr. Erminia Massarelli,
Professor, City of Hope, USA
Dr. Stefan J. Platz,
Senior Vice President, AstraZeneca, UK
Dr. John J. Miles,
Professor, James Cook University, Australia
Dr. Daniel Bradley,
Associate Director, Biogen, USA
Dr. Immanuel Lerner,
Chief Executive Officer, Pepticom LTD, Isreal
Dr. Anthony W. Coleman,
Research Director, Université de Lyon, France
Dr. Mircea Ciuca,
Head, Medical Clinical Drug Safety, ViforPharma, Switzerland
Dr. Lucas P.J.J. Noldus,
Founder & CEO, Noldus Information Technology bv, the Netherlands
Dr. Wilbur de Kruijf,
VP, MedsprayPharma, the Netherlands
Dr. Hubert Pellikaan,
NextstepPharma BV, the Netherlands
Dr. Faz Chowdhury,
CEO, NemauraPharma Limited, UK
Dr. Joël Richard,
Head of Technical and Pharmaceutical Operations, MedinCell, France
Dr. Khursheed Anwer,
Executive Vice President & Chief Science Officer, Celsion Corporation, USA
Dr. Michael Gamlen,
Chief Scientific Officer, Gamlen Tableting Ltd., UK
Dr. Michael Black,
Head of Sales PHARMA, BENEO-Palatinit GmbH, Germany
Dr. Masha Poyurovsky,
VicePresident, Kadmon Corporation, LLC, USA
Dr. Yaakov Naparstek,
Professor of Medicine, Hadassah University Hospital, Israel
Dr. Michael Reilly,
Executive Director, Alliance for Safe Biologic Medicine, USA
Dr. Luana Pesco Koplowitz,
Chief Medical & Scientific Officer, DUCK FLATS Pharma, USA
Dr. Tom Mander,
Chief Operating Officer, Domainex Ltd, UK
Dr. Lars Neumann,
Director, Proteros biostructures GmbH, Germany
Dr. Raphael Serreau,
Professor, Unité INSERM “Psycomadd“ Université Paris Sud, France
Dr. Sigrid Saaler-Reinhardt,
Director, Midas Pharma GmbH, Germany
Dr. Monica Berrondo,
CEO, Macromoltek - Molecular simulations simplified, USA
Dr. Andrea Cusack,
CBO, Leon-nanodrugs GmbH, Germany
Dr. Hiroyuki Fukase,
Director, Clinical Research Center, Clinical Research Hospital Tokyo, Japan
Dr. Didier Dubreuil,
Professor, University of Nantes, France
Dr. Gilles Courtemanche,
Associate Director, Antimicrobials Unit, BIOASTER, France
Dr. Eduard Stefan,
Head, Institute of Biochemistry, University of Innsbruck, Austria
Dr. Albin (Jim) Nelson,
Senior Principal/Owner, Schwegman Lundberg Woessner P.A., USA
Dr. Isaac Bright,
Chief Executive Officer, RubrYc Therapeutics, Inc, USA
Dr. Anna Birukova,
Professor of Medicine, University of Maryland, USA
Dr. Konstantin Birukov,
Professor of Anesthesiology, University of Maryland, USA
Dr. Ralf Glatthar,
Director, Novartis Pharma AG, Switzerland
Dr. Barry Morgan,
CSO, Hitgen Ltd., USA
Dr. Roberta Bursi,
Vice President R&D, InSilicoTrials Technologies, Italy
Dr. Sergey Suchkov,
Director of The Center for Personalized Medicine, I.M. Sechenov First Moscow State Medical University, Russia
Dr. Michael Ovadia,
Professor, Tel Aviv University, Israel
Dr. Lakshminarayan R. Ranganath,
Professor, University of Liverpool, UK
Dr. Karin Schutze,
CSO, CellTool GmbH, Germany
Dr. Andrew Hanneman,
Associate Director, Mass Spectrometry, Charles River Laboratories, USA
Dr. Steven van Helden,
Chief Technology Officer, Pivot Park Screening Centre B.V., Netherlands
Dr. Elaine M. Hull,
Professor, Florida State University, USA
Exhibition and Poster

IDDST-2023 provides an ideal platform to showcase your novel technologies and products in the Netherlands. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.

Why Reserve a Booth at IDDST-2023
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall


Exhibition Date:
Set-up date: July 11, 2023
Show dates: July 12-14, 2023
Place: Amsterdam, the Netherlands

Introduction to Amsterdam

Amsterdam is the capital city and most populous municipality of the Netherlands. Its status as the capital is mandated by the Constitution of the Netherlands. Amsterdam's main attractions include its historic canals, the Rijksmuseum, the Van Gogh Museum, the Stedelijk Museum, Hermitage Amsterdam, the Anne Frank House, the Scheepvaartmuseum, the Amsterdam Museum, the Heineken Experience, the Royal Palace of Amsterdam, Natura Artis Magistra, Hortus Botanicus Amsterdam, NEMO, the red-light district and many cannabis coffee shops. They draw more than 5 million international visitors annually. The city is also well known for its nightlife and festival activity; several of its nightclubs (Melkweg, Paradiso) are among the world's most famous. It is also one of the world's most multicultural cities, with at least 177 nationalities represented.

Conference Chairman

Dr. Godefridus J Peters, Professor, Amsterdam University Medical Centers, the Netherlands
Hosting Organizations
World High Technology Society
Dalian Biteomics, Inc.
Supporting Organizations

International Transmembrane Transporter Society

International Society of Digital Medicine

The Asian Society of Natural Products

UK Pharmacogenetics and Stratified Medicine Network

The Czech Pharmaceutical Society 

The National Hospital Pharmacists Association of Romanian

Journal Partner
Media Partner List

© 2003-2023 All rights reserved by BITeomics
Contact Us:Tel:0086-411-84799609,